Boston Scientific (BSX) stock rises as the company beats Q3 forecasts and raises full-year outlook thanks to strong ...

What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the ...

Boston Scientific reported third-quarter 2025 results that exceeded analyst expectations, with revenue rising to US$5.07 ...

Boston Scientific posts strong Q3 growth and upgrades 2025 outlook. See why BSX stock is rated Buy and what drives its ...

Boston Scientific (BSX) delivered standout earnings growth, with profits up 18.5% per year over the last five years and a ...

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results ...

Boston Scientific (BSX) closed at $95.41 in the latest trading session, marking a -1.92% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 2.71% for the day.

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first ...